Intellectual Property Litigation Partner Recognized by PTAB Bar Association
Inge Osman was honored for her active practice before the Patent Trial and Appeal Board.
Latham brings vast trial experience, technical prowess, and a winning track record across US and global venues to the most complex and mission-critical patent disputes.
For each patent case we field a team led by trial counsel who is experienced litigating in the relevant jurisdiction, whether in the Eastern District of Texas, the District Courts of California, the International Trade Commission, the Federal Circuit, or any number of global venues.
Our global footprint provides clients a distinct advantage — particularly when faced with complex controversies involving technologies developed around the globe. We also regularly achieve successful results in patent mediations, arbitrations, and other forms of alternative dispute resolution as an alternative to protracted litigation.
By conveying command of the technical subject matter and a willingness to go to trial — with the capabilities and experience needed to win — we can often drive opposing counsel back to the negotiating table with a favorable settlement proposal in hand. Our trial counsel commit to the case from day one, developing a strategy while evaluating opportunities for resolution and preparing the case for trial. Because of this targeted and focused approach, we identify key trial issues early and avoid wasteful litigation tasks such as unnecessary discovery and motion practice — an approach that drives efficiency and results.
Inge Osman was honored for her active practice before the Patent Trial and Appeal Board.
Doug Lumish was honored among California’s leading IP lawyers for his recent victories, including in a patent litigation appeal at the Federal Circuit, and for his ability to step in on the eve of trial to supplement clients’ teams and lead them to victory.
A Latham team led by Mike Morin and David Frazier won the “Litigators of the Week” competition, alongside co-counsel at Finnegan, for their outstanding defense against a US$290 million patent infringement claim and securing a US$116 million award on behalf of Sarepta Therapeutics, in a one-week timed trial in Delaware.